Chiara Novello

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Theranostic application of miR-429 in HER2+ breast cancer.

Theranostic application of miR-429 in HER2+ breast cancer.

Journal: Theranostics

Published: May 03, 2019

miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.

miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: November 14, 2016

Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma.

Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma.

Journal: American journal of cancer research

Published: October 01, 2015

p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.

p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.

Journal: PloS one

Published: September 03, 2014

miR-196a expression in human and canine osteosarcomas: a comparative study.

miR-196a expression in human and canine osteosarcomas: a comparative study.

Journal: Research in veterinary science

Published: August 06, 2014

Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study.

Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study.

Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society

Published: May 30, 2014

Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.

Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.

Journal: Genes, chromosomes & cancer

Published: December 09, 2013

Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.

Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.

Journal: Oncology reports

Published: June 12, 2013

[Expression of Concern] Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.

[Expression of Concern] Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.

Journal: Oncology reports

Published: June 12, 2013

Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors.

Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 16, 2013

Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways.

Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways.

Journal: Clinical & experimental metastasis

Published: February 25, 2013

miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.

miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.

Journal: International journal of oncology

Published: June 29, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026